Sangeeta Chakraborty

Sangeeta Chakraborty, PhD, is a seasoned medical writer with extensive experience in the pharmaceutical and biopharma sectors, currently serving at Oxford PharmaGenesis since December 2022, focusing on rare diseases and various therapeutic areas. Prior roles include Senior Medical Writer at Lockwood, where responsibilities encompassed advisory boards and landscape assessments, and Medical Writer positions specializing in myelofibrosis and CLL/SLL at Vaniam Group, as well as work at VMLY&R, developing engaging content for rare diseases. A background in oncology and immunotherapy was established at GeneOnline, while foundational expertise in pulmonology was gained at National Jewish Health. Sangeeta earned a postdoctoral fellowship in Microbiology and Immunology from the University of Colorado Anschutz Medical Campus, following a PhD from the Indian Institute of Science. Additional academic qualifications include an MS in Biochemistry and Molecular Biology and a BS in Biology.